Email
Supergut harnesses the science of the gut microbiome to improve metabolic health through food. When I joined in September 2022 as the company’s first dedicated marketing leader, the brand was a well-kept secret—selling exclusively direct-to-consumer, with a strong scientific foundation but limited market reach and an unclear positioning in a crowded field.
Over the next two and a half years, I built its growth engine from the ground up across product marketing, social, influencer, and retail—and led the strategic pivot that defined the brand’s breakout: repositioning Supergut squarely in the emerging GLP-1 space just as it exploded into the mainstream.
From our packaging and website to email and ads, I overhauled every customer-facing touchpoint to align with our new strategy. I then led our expansion from a pure DTC model into an omnichannel one, landing distribution at Amazon, Target, GNC, Sprouts, Erewhon, and more, for a total of 10,000 retail doors.
The most consequential move was timing. As GLP-1's captured public attention and millions of Americans began exploring weight management, I saw an opportunity to reposition Supergut not as just another gut health brand, but as a triple-action alternative, complement, and off-ramp to GLP-1 meds.
The result: annual revenue tripled to $25M while customer acquisition costs dropped 70%. Validating our bet, our newfound growth trajectory culminated in a $14M Series B investment in November 2024.
